Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China.
Yangzhong ZhouChaojun HuWanting QiYin LongCan HuangQian WangXinping TianJiu-Liang ZhaoMengtao LiXiao-Feng ZengPublished in: Lupus science & medicine (2023)
Anti-β2GPI-DI IgG was associated with extra-criteria manifestations in patients with APS. Further studies are warranted to validate its predictive values and potential role in daily practice.